Sight Sciences (SGHT) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn | 8.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.29% |
| Dec 31, 2025 | 64.87% |
| Sep 30, 2025 | 26.18% |
| Jun 30, 2025 | 3.15% |
| Mar 31, 2025 | 12.98% |
| Dec 31, 2024 | -10.80% |
| Sep 30, 2024 | 15.11% |
| Jun 30, 2024 | 16.44% |
| Mar 31, 2024 | 4.69% |
| Dec 31, 2023 | 36.77% |
| Sep 30, 2023 | 41.36% |
| Jun 30, 2023 | 38.12% |
| Mar 31, 2023 | 26.63% |
| Dec 31, 2022 | -6.09% |
| Sep 30, 2022 | -29.47% |
| Jun 30, 2022 | -35.36% |
| Mar 31, 2022 | -90.06% |
| Dec 31, 2021 | -75.02% |
| Sep 30, 2021 | -112.04% |
| Jun 30, 2021 | -111.82% |